Human Trial Of Experimental HIV Vaccine Ends In Failure In South Africa, Researchers Announce

Washington Post: Trial of promising HIV vaccine fails in South Africa
“A broad study of a promising vaccine for HIV has ended in failure after an interim analysis showed it was no more effective than placebo, researchers announced Monday. Vaccinations were halted after an independent monitoring panel for the ‘Uhambo’ study in South Africa determined on Jan. 23 that 129 people who received the vaccine developed HIV while 123 who were given a placebo contracted the infection…” (Bernstein, 2/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.